glp 1 lily Lilly to pour $6.5 billion into GLP-1 pill manufacturing site Eli Lilly Is More Than

GLP-1 is a hormone your body makes

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record

Ozempic is everywhere, from headlines to households but what do Americans think about weight loss drugs

Learn exactly how long GLP-1 medications take to work

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it shifts its business from selling compounded weight loss drugs to branded GLP-1 medications.